Felipe C. Albuquerque
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Felipe C. Albuquerque has a total of 319 co-authors. Here are the top co-authors by number of shared publications:
Andrew F Ducruet
Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona, USA
20 shared publications- Tyler S. Cole
Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona
17 shared publications Joshua S Catapano
Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
16 shared publicationsJacob F Baranoski
Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA
15 shared publications- Joshua Stephen Catapano
Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona, USA
15 shared publications Caleb Rutledge
Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA
14 shared publications
Latest Publications
- Open Access
- 1 August 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 320
Safety of argatroban to address heparin hypersensitivity in open and interventional carotid procedures
Background: Heparin-induced thrombocytopenia or heparin-induced hypersensitivity reactions pose a challenge for periprocedural anticoagulation. Direct thrombin inhibitors are an alternative anticoagulant; however, limited literature is available regarding argatroban use in neurovascular procedures. Case Description: We describe a patient with symptomatic carotid stenosis undergoing angiography and stent placement with an attempted argatroban loading bolus. Stenting was aborted because of plaque morphology, and therapeutic anticoagulation was not reached. The patient underwent carotid endarterectomy with a higher-dose argatroban administration protocol given the previous subtherapeutic anticoagulation during angiography. Argatroban bolus (150 µg/kg) and maintenance infusion (5 µg/kg/min) with argatroban irrigation (0.5 mg/mL, 250 mL total prepared) were used without complication. Conclusion: We reviewed the safety of argatroban in reports from eight institutions, including intraoperative use for eight patients and periprocedural use for 178 patients. Reports demonstrated no argatroban-related complications.
- 1 August 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 320
Open AccessSafety of argatroban to address heparin hypersensitivity in open and interventional carotid procedures
Background: Heparin-induced thrombocytopenia or heparin-induced hypersensitivity reactions pose a challenge for periprocedural anticoagulation. Direct thrombin inhibitors are an alternative anticoagulant; however, limited literature is available regarding argatroban use in neurovascular procedures. Case Description: We describe a patient with symptomatic carotid stenosis undergoing angiography and stent placement with an attempted argatroban loading bolus. Stenting was aborted because of plaque morphology, and therapeutic anticoagulation was not reached. The patient underwent carotid endarterectomy with a higher-dose argatroban administration protocol given the previous subtherapeutic anticoagulation during angiography. Argatroban bolus (150 µg/kg) and maintenance infusion (5 µg/kg/min) with argatroban irrigation (0.5 mg/mL, 250 mL total prepared) were used without complication. Conclusion: We reviewed the safety of argatroban in reports from eight institutions, including intraoperative use for eight patients and periprocedural use for 178 patients. Reports demonstrated no argatroban-related complications.
- Open Access
- 14 July 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (8) , 787
Farewell
- 14 July 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (8) , 787
Open AccessFarewell
- 14 July 2025
- Vol. 17 (8) , 787
Farewell.
- Open Access
- 29 April 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (3) , 782-789
Higher risk of recurrence in partially thrombosed cerebral aneurysms post-WEB (Woven EndoBridge) device treatment: insights from the WorldWideWEB Consortium registry
Background The Woven EndoBridge (WEB) device is a prevalent treatment for intracranial aneurysms. While many studies have assessed the obliteration rate post-WEB embolization, few have focused on long-term outcomes in partially thrombosed aneurysms. Objective To assess whether partially thrombosed aneurysms are at higher risk of recurrence or retreatment following WEB embolization compared with non-thrombosed aneurysms. Methods We evaluated data from 22 academic institutions, focusing on previously untreated cerebral aneurysms treated with the WEB device. Logistic regression was utilized to analyze factors predicting long-term aneurysm obliteration and retreatment necessity. Results Among 1303 patients, 26 presented with a partially thrombosed aneurysm. In the partially thrombosed group, the mean aneurysm maximal diameter was 10.7±4 mm with a neck ratio of 1.99±1.19 mm, larger than in the control group where the mean aneurysm maximal diameter was 6.81±2.37 mm with a neck ratio of 1.64±0.51 mm (PConclusion Partially thrombosed aneurysms are associated with a poorer occlusion rate and a higher rate of retreatment following WEB embolization. For partially thrombosed aneurysms, the WEB device appears suboptimal as a first-line treatment, and therefore alternative techniques should be prioritized.
- 29 April 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (3) , 782-789
Open AccessHigher risk of recurrence in partially thrombosed cerebral aneurysms post-WEB (Woven EndoBridge) device treatment: insights from the WorldWideWEB Consortium registry
Background The Woven EndoBridge (WEB) device is a prevalent treatment for intracranial aneurysms. While many studies have assessed the obliteration rate post-WEB embolization, few have focused on long-term outcomes in partially thrombosed aneurysms. Objective To assess whether partially thrombosed aneurysms are at higher risk of recurrence or retreatment following WEB embolization compared with non-thrombosed aneurysms. Methods We evaluated data from 22 academic institutions, focusing on previously untreated cerebral aneurysms treated with the WEB device. Logistic regression was utilized to analyze factors predicting long-term aneurysm obliteration and retreatment necessity. Results Among 1303 patients, 26 presented with a partially thrombosed aneurysm. In the partially thrombosed group, the mean aneurysm maximal diameter was 10.7±4 mm with a neck ratio of 1.99±1.19 mm, larger than in the control group where the mean aneurysm maximal diameter was 6.81±2.37 mm with a neck ratio of 1.64±0.51 mm (PConclusion Partially thrombosed aneurysms are associated with a poorer occlusion rate and a higher rate of retreatment following WEB embolization. For partially thrombosed aneurysms, the WEB device appears suboptimal as a first-line treatment, and therefore alternative techniques should be prioritized.
- 26 March 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (2) , 324-331
Multicenter analysis of flow diversion for recurrent/persistent intracranial aneurysms after stent-assisted coiling
Background Flow-diverter stents (FDS) have become the standard of care for a wide range of intracranial aneurysms, but their efficacy/safety in the context of recurrent/recanalized aneurysms following stent-assisted coiling (SAC) is not well established. We evaluate the outcomes of FDS retreatment in a large multicenter cohort. Methods We retrospectively analyzed data from 118 patients across 22 institutions who underwent FDS retreatment for recurrent/persistent aneurysms after SAC (2008–22). The primary outcome was angiographic occlusion status at last follow-up, categorized as complete (100%), near-complete (90–99%), or incomplete (Results A total of 118 patients (median age 57, 74.6% female) with median follow-up of 15.3 months were identified. Complete occlusion was achieved in 62.5% and near-complete occlusion in 25%. FDS deployment within the pre-existing stent was successful in 98.3% of cases. Major complications occurred in 3.4% of cases, including postoperative aneurysmal rupture with resultant mortality (1.6%) and thromboembolic events with long-term disability (1.6%). Favorable clinical outcomes (mRS 0–2) were observed in 95.1% of patients. Wider aneurysm neck diameter was a significant predictor of incomplete occlusion (adjusted OR (aOR) 1.23 per mm, P=0.044), with male sex trending towards association with non-occlusion (aOR 3.2, P=0.07), while baseline hypertension was associated with complete occlusion (aOR 0.32, P=0.048). Conclusions FDS treatment for recurrent/residual aneurysms after SAC represents a viable treatment option for these challenging cases with acceptable safety and reasonable occlusion rates, although lower than de novo FDS occlusion rates.
- 26 March 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (2) , 324-331
Multicenter analysis of flow diversion for recurrent/persistent intracranial aneurysms after stent-assisted coiling
Background Flow-diverter stents (FDS) have become the standard of care for a wide range of intracranial aneurysms, but their efficacy/safety in the context of recurrent/recanalized aneurysms following stent-assisted coiling (SAC) is not well established. We evaluate the outcomes of FDS retreatment in a large multicenter cohort. Methods We retrospectively analyzed data from 118 patients across 22 institutions who underwent FDS retreatment for recurrent/persistent aneurysms after SAC (2008–22). The primary outcome was angiographic occlusion status at last follow-up, categorized as complete (100%), near-complete (90–99%), or incomplete (Results A total of 118 patients (median age 57, 74.6% female) with median follow-up of 15.3 months were identified. Complete occlusion was achieved in 62.5% and near-complete occlusion in 25%. FDS deployment within the pre-existing stent was successful in 98.3% of cases. Major complications occurred in 3.4% of cases, including postoperative aneurysmal rupture with resultant mortality (1.6%) and thromboembolic events with long-term disability (1.6%). Favorable clinical outcomes (mRS 0–2) were observed in 95.1% of patients. Wider aneurysm neck diameter was a significant predictor of incomplete occlusion (adjusted OR (aOR) 1.23 per mm, P=0.044), with male sex trending towards association with non-occlusion (aOR 3.2, P=0.07), while baseline hypertension was associated with complete occlusion (aOR 0.32, P=0.048). Conclusions FDS treatment for recurrent/residual aneurysms after SAC represents a viable treatment option for these challenging cases with acceptable safety and reasonable occlusion rates, although lower than de novo FDS occlusion rates.
- 20 December 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (1) , 1-3
Evidence for middle meningeal artery embolization for chronic subdural hematoma
The surgical arm of the EMBOLISE trial studied MMAE with Onyx (Medtronic, Minneapolis, Minnesota, USA) plus surgery for cSDH compared with surgery alone.5 Patients aged 18–90 were eligible if they had symptomatic unilateral cSDH and underwent surgery, with the following additional criteria: neurological deficit or severe symptoms attributable to the cSDH, maximum cSDH thickness >15 mm and/or midline shift ≥5 mm, and baseline modified Rankin Scale (mRS) score of 0–3. Notable exclusion criteria were bilateral symptomatic cSDH and previous surgery with recurrent SDH.
- 20 December 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (1) , 1-3
Evidence for middle meningeal artery embolization for chronic subdural hematoma
The surgical arm of the EMBOLISE trial studied MMAE with Onyx (Medtronic, Minneapolis, Minnesota, USA) plus surgery for cSDH compared with surgery alone.5 Patients aged 18–90 were eligible if they had symptomatic unilateral cSDH and underwent surgery, with the following additional criteria: neurological deficit or severe symptoms attributable to the cSDH, maximum cSDH thickness >15 mm and/or midline shift ≥5 mm, and baseline modified Rankin Scale (mRS) score of 0–3. Notable exclusion criteria were bilateral symptomatic cSDH and previous surgery with recurrent SDH.
- 17 September 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (1) , 4-5
Supply cost bundling in acute ischemic stroke treatment
Mechanical thrombectomy is the standard of care for anterior circulation large vessel occlusions and is increasingly used for posterior circulation large vessel occlusions.5 6 To ameliorate the costs of this procedure, manufacturer-driven bundling programs have been developed in which all of the necessary devices are purchased together, as opposed to each device being purchased individually (ie, à la carte).7 These programs were previously shown to be cost-effective for stroke care in a study by Munich et al that demonstrated an average savings per case of US$2900.93.7
- 17 September 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (1) , 4-5
Supply cost bundling in acute ischemic stroke treatment
Mechanical thrombectomy is the standard of care for anterior circulation large vessel occlusions and is increasingly used for posterior circulation large vessel occlusions.5 6 To ameliorate the costs of this procedure, manufacturer-driven bundling programs have been developed in which all of the necessary devices are purchased together, as opposed to each device being purchased individually (ie, à la carte).7 These programs were previously shown to be cost-effective for stroke care in a study by Munich et al that demonstrated an average savings per case of US$2900.93.7
- 11 June 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (9) , 1024
Transcirculation retrograde placement of a Pipeline embolization device for treatment of a vertebrobasilar junction aneurysm
Transcirculation catheterization, also known as the retrograde approach, involves the navigation of a catheter or other endovascular device from one arterial circulation to the other (right to left, or anterior to posterior).1–4 We present a case of a complex vertebrobasilar junction aneurysm previously treated by bilateral vertebral artery deconstruction, precluding antegrade access (video 1). Following the creation of a protective occipital artery to posterior inferior cerebellar artery (PICA) bypass, the patient was treated with transcirculation placement of a Pipeline embolization device (PED).5–9 The right internal carotid artery was accessed with a guide catheter using a transradial approach. The microwire–microcatheter combination was then tracked through the right posterior communicating artery, down the basilar trunk, and to the left PICA. The PED was successfully deployed from the left vertebral artery to the mid-basilar artery. At 3-month follow-up, the aneurysm was completely obliterated. The nuances of transcirculation technique, especially for flow diversion, are discussed. (Used with permission from Barrow Neurological Institute, Phoenix, Arizona, USA.) Video 1 Transcirculation retrograde placement of a Pipeline embolization device for treatment of a vertebrobasilar junction aneurysm previously treated by bilateral vertebral artery deconstruction, precluding antegrade access:
- 11 June 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (9) , 1024
Transcirculation retrograde placement of a Pipeline embolization device for treatment of a vertebrobasilar junction aneurysm
Transcirculation catheterization, also known as the retrograde approach, involves the navigation of a catheter or other endovascular device from one arterial circulation to the other (right to left, or anterior to posterior).1–4 We present a case of a complex vertebrobasilar junction aneurysm previously treated by bilateral vertebral artery deconstruction, precluding antegrade access (video 1). Following the creation of a protective occipital artery to posterior inferior cerebellar artery (PICA) bypass, the patient was treated with transcirculation placement of a Pipeline embolization device (PED).5–9 The right internal carotid artery was accessed with a guide catheter using a transradial approach. The microwire–microcatheter combination was then tracked through the right posterior communicating artery, down the basilar trunk, and to the left PICA. The PED was successfully deployed from the left vertebral artery to the mid-basilar artery. At 3-month follow-up, the aneurysm was completely obliterated. The nuances of transcirculation technique, especially for flow diversion, are discussed. (Used with permission from Barrow Neurological Institute, Phoenix, Arizona, USA.) Video 1 Transcirculation retrograde placement of a Pipeline embolization device for treatment of a vertebrobasilar junction aneurysm previously treated by bilateral vertebral artery deconstruction, precluding antegrade access:
- 11 April 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 16 (10) , 1033-1035
Evaluation of ChatGPT in knowledge of newly evolving neurosurgery: middle meningeal artery embolization for subdural hematoma management
ChatGPT (version 4.0) was tasked with writing a 2700-word review regarding the technique of MMAE for chronic subdural hematoma as well as its indications, evidence of clinical utility, limitations, and future directions. The precise prompt used to query ChatGPT was, ‘GPT-4, middle meningeal artery embolization is a procedure performed for subdural hematomas. Write a 2700-word review …
- 11 April 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 16 (10) , 1033-1035
Evaluation of ChatGPT in knowledge of newly evolving neurosurgery: middle meningeal artery embolization for subdural hematoma management
ChatGPT (version 4.0) was tasked with writing a 2700-word review regarding the technique of MMAE for chronic subdural hematoma as well as its indications, evidence of clinical utility, limitations, and future directions. The precise prompt used to query ChatGPT was, ‘GPT-4, middle meningeal artery embolization is a procedure performed for subdural hematomas. Write a 2700-word review …
- 18 January 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (e1) , e15-e24
The impact of postoperative aspirin in patients undergoing Woven EndoBridge: a multicenter, institutional, propensity score-matched analysis
Background The Woven EndoBridge (WEB) device is frequently used for the treatment of intracranial aneurysms. Postoperative management, including the use of aspirin, varies among clinicians and institutions, but its impact on the outcomes of the WEB has not been thoroughly investigated. Methods This was a retrospective, multicenter study involving 30 academic institutions in North America, South America, and Europe. Data from 1492 patients treated with the WEB device were included. Patients were categorized into two groups based on their postoperative use of aspirin (aspirin group: n=1124, non-aspirin group: n=368). Data points included patient demographics, aneurysm characteristics, procedural details, complications, and angiographic and functional outcomes. Propensity score matching (PSM) was applied to balance variables between the two groups. Results Prior to PSM, the aspirin group exhibited significantly higher rates of modified Rankin scale (mRS) mRS 0–1 and mRS 0–2 (89.8% vs 73.4% and 94.1% vs 79.8%, pConclusions Aspirin use post-WEB treatment may lead to better functional outcomes and lower mortality but with higher retreatment rates. These insights are crucial for postoperative management after WEB procedures, but further studies are necessary for validation.
- 18 January 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (e1) , e15-e24
The impact of postoperative aspirin in patients undergoing Woven EndoBridge: a multicenter, institutional, propensity score-matched analysis
Background The Woven EndoBridge (WEB) device is frequently used for the treatment of intracranial aneurysms. Postoperative management, including the use of aspirin, varies among clinicians and institutions, but its impact on the outcomes of the WEB has not been thoroughly investigated. Methods This was a retrospective, multicenter study involving 30 academic institutions in North America, South America, and Europe. Data from 1492 patients treated with the WEB device were included. Patients were categorized into two groups based on their postoperative use of aspirin (aspirin group: n=1124, non-aspirin group: n=368). Data points included patient demographics, aneurysm characteristics, procedural details, complications, and angiographic and functional outcomes. Propensity score matching (PSM) was applied to balance variables between the two groups. Results Prior to PSM, the aspirin group exhibited significantly higher rates of modified Rankin scale (mRS) mRS 0–1 and mRS 0–2 (89.8% vs 73.4% and 94.1% vs 79.8%, pConclusions Aspirin use post-WEB treatment may lead to better functional outcomes and lower mortality but with higher retreatment rates. These insights are crucial for postoperative management after WEB procedures, but further studies are necessary for validation.